Organization
Fred Hutchinson Cancer Research Center
68 abstracts
2 posters
Abstract
Effects of ovarian ablation or suppression on breast cancer recurrence and survival: Patient-level meta-analysis of 14,993 pre-menopausal women in 25 randomized trials.Org: University of Oxford, Centre for Public Health, Karolinska Institutet, Fred Hutchinson Cancer Research Center, Peter MacCallum Cancer Centre, Melbourne, Australia,
Abstract
SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC).Org: University of Virginia, Charlottesville, VA, USA, Fred Hutchinson Cancer Research Center, Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Levine Cancer Institute,
Abstract
Medicaid enrollment changes among U.S. adult survivors of childhood cancer following Medicaid expansion: A report from the Childhood Cancer Survivor Study (CCSS).Org: Atlanta, GA, Seattle, WA, Toronto, ON, Canada, Memphis, TN, Salt Lake City, UT,
Abstract
Risk of early mortality in patients with cancer experiencing adverse financial events.Org: University of Washington/Fred Hutch Cancer Center, University of Washington School of Medicine, University of Washington, Fred Hutchinson Cancer Center, Fred Hutchinson Cancer Center, Fred Hutchinson Cancer Research Center,
Abstract
Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.Org: Fred Hutchinson Cancer Research Center, University of Michigan, Lewis Cancer & Research Pavilion at St. Joseph's Candler/GA NCORP, Bon Secours Cancer Institute at St. Francis, Cancer & Hematology Centers of Western Michigan,
Abstract
Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.Org: Weill Cornell Medicine, Mount Sinai Hospital-Breast Medical Oncology, Massachusetts General Hospital, UM/Sylvester Comprehensive Cancer Center, UNC Patient Advocates for Research Council,
Abstract
ECOG-ACRIN E2197: Comparison of HER2 gene expression by RT-PCR across all HER2 immunohistochemistry groups with recurrence analysis.Org: Exact Sciences Corporation, Genomic Health Inc, Fred Hutchinson Cancer Research Center, Tisch Cancer Institute, Fox Chase Cancer Center,
Abstract
Menopausal hormone therapy and ovarian and endometrial cancers: Long-term follow-up of the Women’s Health Initiative randomized trials.Org: The Lundquist Research Institute, Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, Fred Hutchinson Cancer Research Center, Kaiser Permanente Southern California, Albert Einstein College of Medicine,
Abstract
Diet quality and cardiometabolic risk factors among breast cancer survivors in the Pathways Study.Org: Division of Research, Kaiser Permanente Northern California, Fred Hutchinson Cancer Research Center, University of Washington Medical Center,
Abstract
Risk prediction model for acute care use among patients with advanced cancer on clinical trials.Org: Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, Fred Hutchinson Cancer Research Center, SWOG Statistics and Data Management Center/Fred Hutchinson Cancer Research Center,
Abstract
End of life (EOL) care in head and neck squamous cell carcinoma (HNSCC) compared to other solid tumors (OST) in Washington (WA) State.Org: Fred Hutchinson Cancer Center, Seattle Gummy Company, Wave Life Sciences, Department of Otolaryngology, University of Pittsburgh, Head and Neck Surgery,
Abstract
Cancer clinical trial participation in socioeconomically vulnerable patients: A risk model to aid in targeted interventions.Org: Arnold Ventures, SWOG Statistics and Data Management Center, Seattle, WA, Fred Hutchinson Cancer Research Center,
Abstract
Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program study.Org: VA Puget Sound Health Care System, Veterans Healthcare Administration, Corporal Michael Crescenz VA Medical Center, Genetic Support Foundation, VA Million Veteran Program,
Abstract
Analyzing correlates for cervical cancer awareness in Mauritania, Madagascar, and Benin from the Demographic Health Survey (DHS): 2017-2022.Org: Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA, Uganda Cancer Institute, Kampala, Uganda,
Abstract
TRAMP study: A phase 2 trial of tumor necrosis factor-α blockade and AR inhibition in men with CRPC.Org: Division of Hematology & Oncology, University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, Fred Hutchinson Cancer Research Center,
Abstract
Sugar-sweetened beverage intake and risk of oral cavity cancer: Results from 3 prospective US cohort studies.Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Research Center, Department of Otolaryngology, Head and Neck Surgery, University of Washington,
Abstract
Correlation of body mass index (BMI) with survival outcomes in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): Analysis of patient (pt)-level data from SWOG 1216 study.Org: Huntsman Cancer Institute at the University of Utah, SWOG Statistics and Data Management Center, Seattle, WA, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Instititute, University of Kentucky, Lexington, KY,
Abstract
The impact of adverse financial events on healthcare utilization and treatment costs at the end of life.Org: Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Seattle Gummy Company, Wave Life Sciences, University of Washington/Fred Hutch Cancer Center, Fred Hutchinson Cancer Research Center,
Abstract
Implications for acute myeloid leukemia (AML) treatment and care during the COVID-19 pandemic: A Connect Myeloid Registry study.Org: Fred Hutchinson Cancer Research Center, Sylvester Comprehensive Cancer Center, Miami, FL, University of Miami Health System, University of Texas MD Anderson Cancer Center, Northshore University Healthsystem,
Abstract
Dual PD1 and CTLA4 immune checkpoint blockade and hypofractionated radiation in patients with salivary gland cancers.Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Division of Hematopathology, Mayo Clinic, Rochester, MN, Virginia Commonwealth University School of Medicine,
Abstract
Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.Org: Fred Hutchinson Cancer Research Center, Seattle, WA, American Society of Clinical Oncology, Alexandria, VA, Friends of Cancer Research, Washington, DC,
Abstract
Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma.Org: Fred Hutchinson Cancer Research Center, Boston University Medical Center, Massachusetts General Hospital, Dana-Farber Cancer Institute, Medical College of Wisconsin,
Abstract
Identification of factors to predict low risk febrile neutropenia admissions in patients with acute myeloid leukemia (AML) following intensive chemotherapy.Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, University of Washington Medical Center, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center,
Abstract
The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.Org: Mount Sinai Health System, SWOG Statistics and Data Management Center, Seattle, WA, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Dana-Farber Cancer Institute, SWOG Statistical Center,
Abstract
Predicting therapy-induced cardiomyopathy in long-term survivors of childhood cancer: A report from the St. Jude Lifetime Cohort (SJLIFE) and the Childhood Cancer Survivor Study (CCSS).Org: St Jude Childrens Research Hospital, St. Jude Children's Research Hospital, University of Minnesota Masonic Cancer Center, Minneapolis, MN, Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, University of Alabama at Birmingham Department of Hematology, Birmingham, AL,
Abstract
AFNT-211: An FAS-41BB–enhanced TCR-T cell therapy with stem-like properties targeting KRAS G12V-expressing solid tumors.Org: Affini-T Therapeutics, Inc., Watertown, NY, MaaT Pharma, Seattle Gummy Company, Wave Life Sciences,
Abstract
The relationship between a priori defined prognostic risk groups and and overall survival (OS) in men with metastatic hormone sensitive prostate cancer (mHSPC).Org: Duke University Medical Center, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, MRC Clinical Trials Unit at UCL, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, SWOG Statistical Center,
Abstract
Plasma cell leukemia: A multicenter retrospective study of 150 patients.Org: The University of Arizona Cancer Center, University of Arizona Cancer Center, The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, Department of Internal Medicine, University of Utah, Fred Hutchinson Cancer Research Center,
Abstract
Fibroblast growth factor receptor 3 (FGFR3) alterations in PROOF 302: A phase III trial of infigratinib (BGJ398) as adjuvant therapy in patients (pts) with invasive urothelial carcinoma (UC).Org: Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, USC Institute of Urology, USC/Norris Comprehensive Cancer Center, Cleveland Clinic Lerner Research Institute, Cleveland, OH,
Abstract
Mortality benefit of a blood-based biomarker panel for lung cancer and the PLCO cohort.Org: University of Texas MD Anderson Cancer Center, Department of General Internal Medicine, Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, MD Anderson Cancer Center,
Abstract
Chemotherapy dose density and effect on prognosis for patients with resectable pancreas cancer: A secondary analysis of SWOG S1505.Org: University of Cincinnati Medical Center, SWOG Statistical Center, University of Cincinnati College of Medicine, Fred Hutchinson Cancer Research Center, SWOG Statistics and Data Management Center, Seattle, WA,
Abstract
A phase 1b/2 study of pivekimab sunirine (PVEK, IMGN632) in combination with venetoclax/azacitidine or magrolimab for patients with CD123-positive acute myeloid leukemia (AML).Org: ImmunoGen, University of Texas MD Anderson Cancer Center, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) IRCCS, Meldola, Italy, Roswell Park Comprehensive Cancer Center, Fred Hutchinson Cancer Research Center,
Abstract
Adjuvant everolimus in patients (Pts) with localized non-clear cell renal cell carcinoma (RCC): Subgroup analysis from the Everest trial (SWOG S0931).Org: University of California Davis Comprehensive Cancer Center, SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Oregon Health & Science University, Knight Cancer Institute,
Abstract
MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).Org: Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Instititute, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, New York-Presbyterian Hospital, The Tisch Cancer Institute,
Abstract
Treatment and survival of de novo metastatic hormone sensitive prostate cancer among African American US Veterans.Org: Washington University School of Medicine in St Louis, University of Washington Medical Center, Fred Hutchinson Cancer Research Center, Washington University in St. Louis, Siteman Cancer Center/Washington University,
Abstract
Baseline circulating tumor cell (CTC) count as a prognostic marker of overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide.Org: Keck School of Medicine of the University of Southern California, Norris Comprehensive Cancer Center, SWOG Statistical Center, Fred Hutchinson Cancer Research Center, USC/Norris Comprehensive Cancer Center,
Abstract
A phase III randomized trial of eribulin (E) with or without gemcitabine vs standard of care (SOC) for metastatic urothelial carcinoma (UC) refractory to or ineligible for PD/PDL1 antibody (Ab): SWOG S1937.Org: SWOG Statistics and Data Management Center, Seattle, WA, University of California Davis Comprehensive Cancer Center, Fred Hutchinson Cancer Research Center, SWOG Cancer Research Network, Baylor College of Medicine,
Abstract
Pirtobrutinib in covalent BTK-inhibitor (cBTKi) pre-treated mantle cell lymphoma (MCL): Updated results and subgroup analysis from the phase 1/2 BRUIN study with >3 years follow-up from start of enrollment.Org: Medical College of Wisconsin, Milwaukee, WI, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland, IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli” and Dipartimento di Medicina Specialistica,
Abstract
Consistency of pacritinib for spleen and symptom reduction in patients with myelofibrosis regardless of cytopenias.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University Medical Center Hamburg-Eppendorf, Princess Margaret Cancer Centre, University Health Network, University College London Hospitals NHS Foundation Trust,
Abstract
Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation (ADT) with or without orteronel (SWOG S1216).Org: University of California Davis Comprehensive Cancer Center, SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Cleveland Clinic Taussig Cancer Instititute,
Abstract
Bone biomarkers and subsequent survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): Results from the phase III SWOG S1216 trial of androgen deprivation +/- orteronel.Org: University of California Davis Comprehensive Cancer Center, SWOG Statistical Center, Western Human Nutrition Research Center, WHNRC, Davis Comprehensive Cancer Center,
Abstract
Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC).Org: Duke University Medical Center, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, MRC Clinical Trials Unit at UCL, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, SWOG Statistical Center,
Abstract
Adherence to surveillance guidelines in survivors of Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study (CCSS).Org: Cleveland Clinic Taussig Cancer Instititute, University of Alberta, St. Jude Children's Research Hospital, Fred Hutchinson Cancer Research Center, University of Minnesota Masonic Cancer Center, Minneapolis, MN,
Abstract
Congenital anomalies and health outcomes among survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.Org: Baylor College of Medicine, Children's Hospital of Philadelphia, National Cancer Institute, Vilnius, Lithuania, Duke University Trent Center for Bioethics Humanities and History of Medicine, Durham, NC, University of Alabama at Birmingham School of Medicine,
Abstract
Incidental discovery of second primary malignancies in patients diagnosed with breast cancer: An institutional case series.Org: Temple University Hospital, Philadelphia, PA, University of Washington/Fred Hutchinson Cancer Research Center, University of Washington and Fred Hutchinson Cancer Research Centre, University of Washington, Cancer Vaccine Institute, Fred Hutchinson Cancer Research Center,
Abstract
The FOR ME (Fostering Opportunities in Research through Messaging and Education) study: Developing a culturally sensitive narrative intervention to promote equity in clinical trials.Org: University of Illinois Chicago, Department of Hematology Oncology University of Illinois of Chicago College of Medicine, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Mount Sinai Hospital,
Abstract
Osimertinib rechallenge in advanced EGFR non-small cell lung cancer patients.Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Research Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, University of Washington School of Medicine,
Abstract
Trends in diagnosis of de novo metastatic hormone sensitive prostate cancer in US Veterans, 2002-2021.Org: St. Louis University, Fred Hutchinson Cancer Research Center, Washington University School of Medicine in St Louis, Saint Louis University School of Medicine, Research Service,
Abstract
Mortality and the burden of subsequent malignant neoplasms in survivors of childhood cancer beyond age 50: A report from the Childhood Cancer Survivor Study (CCSS).Org: City of Hope National Medical Center, University of Alberta, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, U T MD Anderson Cancer Center, Dana-Farber Cancer Institute,
Abstract
Subsequent meningiomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).Org: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, University of Alberta, University of Minnesota Masonic Cancer Center, Minneapolis, MN, Fred Hutchinson Cancer Research Center, MD Anderson Cancer Center,
Abstract
Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study (CCSS) report.Org: Cancer and Blood Disorders Center, Seattle Children's Hospital, St. Jude Children's Research Hospital, CHOC Hem, Department of Pediatrics & Adolescent Medicine, Queen Mary Hospital,
Abstract
Association of measures of socioeconomic deprivation with healthcare utilization in elderly patients enrolled in SWOG cancer clinical trials.Org: Columbia University Medical Center, New York, NY, SWOG Statistics and Data Management Center, Seattle, WA, Seattle, WA, Fred Hutchinson Cancer Research Center,
Abstract
Association of quantitative MRI features of DCIS with surgical upstaging and recurrence after treatment.Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Research Center, Fred Hutch Cancer Center, University of Washington Medical Center,
Abstract
Long term survival in patients with bony oligometastatic breast cancer treated with curative intent: An institutional case series.Org: Temple University Hospital, Philadelphia, PA, University of Washington and Fred Hutchinson Cancer Research Centre, University of Washington, Cancer Vaccine Institute, Fred Hutchinson Cancer Research Center,
Abstract
B7H3 expression in sarcoma.Org: Northwestern Memorial Hospital, Chicago, IL, Chicago, IL, Northwestern University-Feinberg School of Medicine, University of Washington and Fred Hutchinson Cancer Research Centre, Seattle, WA,
Abstract
The 2022 NCI Community Oncology Research Program (NCORP) Landscape Committee Assessment: Methods and participating practice group characteristics.Org: Wake Forest University School of Medicine, University of Alabama at Birmingham Department of Hematology, Birmingham, AL, University of Wisconsin School of Medicine and Public Health, Tufts Medical Center/Tufts University, Spartanburg Regional Healthcare System,
Abstract
Adherence to statins and risk of cardiovascular disease in patients with breast cancer.Org: Division of Research Services, Kaiser Permanente Northern California, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center,
Abstract
Survival of de novo metastatic hormone sensitive prostate cancer in US Veterans based on treatment and PSA at diagnosis.Org: Saint Louis University School of Medicine, University of Washington Medical Center, Fred Hutchinson Cancer Research Center, St. Louis University, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine,
Abstract
Effect of change in ECOG performance status at diagnosis and relapse in patients with acute myeloid leukemia.Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Hematology Division at University of Washington Medical Center, University of Washington Medical Center, Seattle Cancer Care Alliance,
Abstract
Estimating burden of cardiovascular disease among survivors of breast, colorectal, lung, and prostate cancer in the Detroit Research on Cancer Survivors (ROCS) cohort.Org: Ascension Providence Hospital/Michigan State University, Barbara Ann Karmanos Cancer Institute, Wayne State University, MedStar Health Research Institute, University of Pittsburgh Medical Center,
Abstract
A genome-wide association study for doxorubicin-induced cardiomyopathy in childhood cancer survivors from the St. Jude Lifetime Cohort (SJLIFE) and the Childhood Cancer Survivor (CCSS) Studies.Org: St Jude Childrens Research Hospital, St. Jude Children's Research Hospital, University of Minnesota Masonic Cancer Center, Minneapolis, MN, Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, University of North Texas Health Science Center,
Abstract
Social determinants of health and neurocognitive and psychosocial outcomes in adult childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS).Org: Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA, Atlanta, GA, School of Public Health, Fudan University, University of Alberta,
Abstract
Factors associated with long-term gastrointestinal toxicity in colorectal cancer survivors in the women’s health initiatives (WHI) study.Org: Ohio State University James Cancer Center, Fred Hutchinson Cancer Research Center, Ohio state university James Cancer Research Center, University of Washington and Fred Hutchinson Cancer Research Centre,
Abstract
Role of HLA-DRB4 as a biomarker for endocrine toxicity and survival outcomes after immunotherapy in metastatic non-small cell lung cancer.Org: University of Michigan, Fred Hutchinson Cancer Research Center, Beaumont Health, University of Michigan Health Management Research Center, Fred Hutchinson Cancer Center/Division of Hematology and Oncology,
Abstract
Primary care utilization and cardiovascular screening in adult-aged survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).Org: Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Alberta, University of Washington and Fred Hutchinson Cancer Research Centre, St. Jude Children's Research Hospital,
Abstract
Darolutamide observational (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: Second interim analysis.Org: Fred Hutchinson Cancer Research Center, University of Washington and Fred Hutchinson Cancer Research Centre, Associated Medical Professionals of NY, Toho University Sakura Medical Center, First Urology,
Abstract
The FOR US (Fostering Opportunities in Research Using Marketing Strategies) study.Org: Fred Hutchinson Cancer Center/Division of Hematology and Oncology, BlockBeta, Fred Hutchinson Cancer Research Center,
Abstract
ADVERSE OUTCOMES AND REHOSPITALIZATION AFTER DELIVERY AMONG WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS OR RHEUMATOID ARTHRITIS AND THEIR INFANTSOrg: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Research Center, University of New Mexico Comprehensive Cancer Center,